CBPO News and Press, China Biologic Products Holdings Inc. From 05/10/19

China Biologic Products (NASDAQ: CBPO ): Q1 Non-GAAP EPS of $1.11 beats by $0.13 ; GAAP EPS of $0.94 beats by $0.26 . Revenue of $129.8M (+15.4% Y/Y) beats by $10.3M . Press Release More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stoc...

--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million ; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING , May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biolog...

CBPO For Seeking Alpha's full earnings season calendar,  click here . More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, ,

BEIJING , April 30, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its first quarter 2019 f...

Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...

China Biologic Products, Inc. (CBPO) Q4 2018 Earnings Conference Call March 07, 2019 07:30 AM ET Company Participants Sam Martin - IR Bing Li - CEO Ming Yin - SVP Ming Yang - CFO Conference Call Participants Yolanda Hu - Morgan Stanley Serena Shao - Credit Suisse Pre...

China Biologic Products (NASDAQ: CBPO ): Q4 Non-GAAP EPS of $0.76 misses by $0.07 ; GAAP EPS of $0.86 beats by $1.71 . More news on: China Biologic Products, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

-- 4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; Net Income Up $59.4 Million YoY to $34.8 Million ; Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms -- -- FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; Net Income Up 88.7% Y...

ABM , ASRT , BLDP , BREW , CBPO , DSGX , FTK , GWRE , HIIQ , WHD , YEXT For Seeking Alpha's full earnings season calendar, click here . More news on: ABM Industries Incorporated, Assertio Therapeutics Inc, Ballard Power Systems, Inc., Earnings news and commentary,

BEIJING , Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its fourth quarter and fi...